Cited by 15,011Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of LifeVoice and Speech Disorders

The DOI matches its Crossref record; 12 of the 13 references it cites were found in a registry or an index.

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Kurtzke, John F.·1983·Neurology

DOI 10.1212/wnl.33.11.1444

Open this paper in CoChat — free account

Abstract

One method of evaluating the degree of neurologic impairment in MS has been the combination of grades (0 = normal to 5 or 6 = maximal impairment) within 8 Functional Systems (FS) and an overall Disability Status Scale (DSS) that had steps from 0 (normal) to 10 (death due to MS). A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 . . . 9) now divided into two (1.0, 1.5, 2.0 . . . 9.5). The lower portion is obligatorily defined by Functional System grades. The FS are Pyramidal, Cerebellar, Brain Stem, Sensory, Bowel & Bladder, Visual, Cerebral, and Other; the Sensory and Bowel & Bladder Systems have been revised. Patterns of FS and relations of FS by type and grade to the DSS are demonstrated.

Integrity signals

Registry

Crossref · 10.1212/wnl.33.11.1444

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

On the evaluation of disability in multiple sclerosis
Kurtzke, J. F. (1961) · Neurology · doi:10.1212/wnl.11.8.686 · Cited by 330
Further notes on disability evaluation in multiple sclerosis, with scale modifications
Kurtzke, J. F. (1965) · Neurology · doi:10.1212/wnl.15.7.654 · Cited by 309
A New Scale for Evaluating Disability in Multiple Sclerosis
Kurtzke, J. F. (1955) · Neurology · doi:10.1212/wnl.5.8.580 · Cited by 305
Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps.
Wood, P. (1980) · PubMed · Cited by 247
NEUROLOGIC IMPAIRMENT IN MULTIPLE SCLEROSIS AND THE DISABILITY STATUS SCALE
Kurtzke, J. F. (1970) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1970.tb05808.x · Cited by 156
A PROPOSAL FOR A UNIFORM MINIMAL RECORD OF DISABILITY IN MULTIPLE SCLEROSIS
Kurtzke, J. F. (1981) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb05548.x · Cited by 127
STUDIES ON THE NATURAL HISTORY OF MULTIPLE SCLEROSIS 6. Clinical and Laboratory Findings at First Diagnosis
Kurtzke, J. F., Beebe, G. W., Nagler, B., Auth, T. L., Kurland, L. T., & Nefzger, M. D. (1972) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1972.tb07525.x · Cited by 68
THE SOCIO-ECONOMIC SCALE
Mellerup, E., Fog, T., Raun, N. E., Colville, P., de Rham, B., Hannah, B., & Kurtzke, J. F. (1981) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb05549.x · Cited by 53
The effects of isoniazid on patients with multiple sclerosis; preliminary report.
Kurtzke, J. F., & Berlin, L. (1954) · PubMed · doi:10.1164/art.1954.70.4.577 · Cited by 23
ACUTE RESPIRATORY FAILURE IN MULTIPLE SCLEROSIS AND ITS MANAGEMENT
Guthrie, T. C., Kurtzke, J. F., & BERLIN, L. (1952) · Annals of Internal Medicine · doi:10.7326/0003-4819-37-6-1197 · Cited by 20

Show all 13 references

Sorted by citations

Items 601–700 of 1,135

Spinal cord gray matter atrophy correlates with multiple sclerosis disability
Schlaeger, R., Papinutto, N., Panara, V., Bevan, C., Lobach, I., Bucci, M., Caverzasi, E., Gelfand, J. M., Green, A., Jordan, K., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24241 · Cited by 202
Brainstem lesions in clinically isolated syndromes
Tintoré, M., Rovira, À., Arrambide, G., Mitjana, R., Río, J., Auger, C., Nos, C., Edo, M. C., Castilló, J., Horga, A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181feb26f · Cited by 197
Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients
Yozbatıran, N., Başkurt, F., Başkurt, Z., Özakbaş, S., & İdıman, E. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.02.018 · Cited by 196
Severity of chronic pain and its relationship to quality of life in multiple sclerosis
Kalia, L. V., & O'Connor, P. W. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1168oa · Cited by 193
Remotely-supervised transcranial direct current stimulation (tDCS) for clinical trials: guidelines for technology and protocols
Charvet, L. E., Kasschau, M., Datta, A., Knotková, H., Stevens, M. C. G., Alonzo, A., Loo, C. K. A., Krull, K. R., & Bikson, M. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00026 · Cited by 195
Screening for Cognitive Impairment in Multiple Sclerosis
Beatty, W. W. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530030069018 · Cited by 196
MRI dynamics of brain and spinal cord in progressive multiple sclerosis.
Kidd, D. P., Thorpe, J. W., Kendall, B. E., Barker, G. J., Miller, D., McDonald, W. I., & Thompson, A. J. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.1.15 · Cited by 196
Guillain‐Barré and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy
Shin, I. J., Baer, A. N., Kwon, H., Papadopoulos, E. J., & Siegel, J. N. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21814 · Cited by 195
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis
Glanz, B., Holland, C. M., Gauthier, S., Amunwa, E., Liptak, Z., Houtchens, M., Sperling, R., Khoury, S. J., Guttmann, C. R. G., & Weiner, H. L. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507077943 · Cited by 195
Cognition in the early stage of multiple sclerosis
Schulz, D., Kopp, B., Kunkel, A., & Faiss, J. H. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0145-8 · Cited by 195
Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability
Charil, A., Dagher, A., Lerch, J. P., Zijdenbos, A. P., Worsley, K. J., & Evans, A. C. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.006 · Cited by 194
Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis.
Rovaris, M., Filippi, M., Minicucci, L., Iannucci, G., Santuccio, G., Possa, F., & Comi, G. (2000) · PubMed Central · Cited by 195
Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging.
Bozzali, M., Cercignani, M., Sormani, M. P., Comı, G., & Filippi, M. (2002) · PubMed Central · Cited by 195
Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis
Filippi, M. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.2.157 · Cited by 193
Effect of low saturated fat diet in early and late cases of multiple sclerosis
Swank, R. L., & Dugan, B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91533-g · Cited by 194
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
On behalf of the BRAVO Study Group, Vollmer, T. R., Sørensen, P. S., Selmaj, K. W., Zipp, F., Havrdová, E., Cohen, J. A., Sasson, N. J., Gilgun‐Sherki, Y., & Arnold, D. L. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7264-4 · Cited by 194
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis
Hill-Cawthorne, G. A., Button, T., Tuohy, O., Jones, J., May, K., Somerfield, J., Green, A. J. E., Giovannoni, G., Compston, D. A. S., Fahey, M. T., et al. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300826 · Cited by 194
Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. residual method
Sanfilipo, M. P., Benedict, R. H. B., Zivadinov, R., & Bakshi, R. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.03.037 · Cited by 194
Telephone-administered cognitive–behavioral therapy for the treatment of depressive symptoms in multiple sclerosis.
Mohr, D. C., Likosky, W., Bertagnolli, A., Goodkin, D. E., Van Der Wende, J., Dwyer, P., & Dick, L. P. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.2.356 · Cited by 240
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
Balcer, L. J., Baier, M. L., Cohen, J. A., Kooijmans, M., Sandrock, A., Nano-Schiavi, M. L., Pfohl, D., Mills, M., Bowen, J. D., Ford, C. C., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000094315.19931.90 · Cited by 190
Plasma exchange for acute attacks of CNS demyelination
Llufriú, S., Castilló, J., Blanco, Y., Ramió‐Torrentà, L., Río, J., Vallès, M., Lozano, M., Castellà, M. D., Calabia, J., Horga, A., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b879be · Cited by 193
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
Cantó, E., Barro, C., Zhao, C., Caillier, S. J., Michalak, Z., Bove, R., Tomic, D., Santaniello, A., Häring, D. A., Hollenbach, J., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2137 · Cited by 199
A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes
Ceccarelli, A., Rocca, M. A., Pagani, E., Colombo, B., Martinelli, V., Comi, G., & Filippi, M. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.173 · Cited by 192
The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis
Sıva, A., & Saip, S. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0145-6 · Cited by 192
Home-Based Balance Training Using the Wii Balance Board
Prosperini, L., Fortuna, D., Giannì, C., Leonardi, L., Marchetti, M. R., & Pozzilli, C. (2013) · Neurorehabilitation and neural repair · doi:10.1177/1545968313478484 · Cited by 192
Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis
Morris, M. E. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.3.361 · Cited by 192
Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis
Audoin, B., Duong, M. V. A., Ranjeva, J., Ibarrola, D., Irina Malikova, A., Sylviane Confort-gouny, A., Soulier, E., Viout, P., Ali‐Chérif, A., Pelletier, J., et al. (2004) · Human Brain Mapping · doi:10.1002/hbm.20083 · Cited by 192
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
Arnold, D. L., Riess, G. T., Matthews, P. M., Francis, G., Collins, D. L., Wolfson, C. M., & Antel, J. P. (1994) · Annals of Neurology · doi:10.1002/ana.410360115 · Cited by 192
Anterograde and Retrograde Amnesia in Patients With Chronic Progressive Multiple Sclerosis
Beatty, W. W., Goodkin, D. E., Monson, N. R., Beatty, P. A., & Hertsgaard, D. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520300029013 · Cited by 191
Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis
Negrotto, L., Farez, M. F., & Correale, J. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4807 · Cited by 198
Information processing speed in patients with multiple sclerosis
Rao, S. M., Aubin-Faubert, P. S., & Leo, G. J. (1989) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638908400907 · Cited by 191
The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope
LYNCH, S. G., Kroencke, D. C., & Denney, D. R. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700611 · Cited by 190
Distinct Neurocognitive Profiles in Multiple Sclerosis Subtypes
Zakzanis, K. K. (2000) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(98)00157-7 · Cited by 191
Oral fingolimod (FTY720) in multiple sclerosis
O'Connor, P. W., Comi, G., Montalbán, X., Antel, J. P., Radue, E. W., de Vera, A., Pohlmann, H., & Kappos, L. (2009) · Neurology · doi:10.1212/01.wnl.0000338569.32367.3d · Cited by 191
Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients
Gosselink, R., Kovács, L., Ketelaer, P., Carton, H., & Decramer, M. (2000) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(00)90105-9 · Cited by 191
The epidemiology of multiple sclerosis
Goodin, D. S. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00010-8 · Cited by 206
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
Axelsson, M., Malmeström, C., Nilsson, S., Haghighi, S., Rosengren, L., & Lycke, J. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5863-2 · Cited by 194
Psychological stress and the subsequent appearance of new brain MRI lesions in MS
Mohr, D. C., Goodkin, D. E., Bacchetti, P., Boudewyn, A. C., Huang, L., Marietta, P., Cheuk, W., & Dee, B. (2000) · Neurology · doi:10.1212/wnl.55.1.55 · Cited by 190
Amantadine for fatigue in multiple sclerosis
Pucci, E., Tato, P. B., D’Amico, R., Giuliani, G., Solari, A., & Taus, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002818.pub2 · Cited by 189
MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study
Verhey, L. H., Branson, H. M., Shroff, M. M., Callen, D. J. A., Sled, J. G., Narayanan, S., Sadovnick, A. D., Bar‐Or, A., Arnold, D. L., Marrie, R. A., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70250-2 · Cited by 189
Distinct subtypes of myelitis in systemic lupus erythematosus
Birnbaum, J., Petri, M., Thompson, R., Izbudak, I., & Kerr, D. A. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24937 · Cited by 190
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
Zivadinov, R., Marr, K., Cutter, G., Ramanathan, M. K., Benedict, R. H. B., Kennedy, C., Elfadil, M., Yeh, E. A., Reuther, J. A., Brooks, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318212a901 · Cited by 189
Resistance Training Improves Gait Kinematics in Persons With Multiple Sclerosis
Gutierrez, G. M., Chow, J. W., Tillman, M. D., McCoy, S. C., Castellano, V., & White, L. J. (2005) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2005.04.008 · Cited by 189
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Zubizarreta, I., Flórez‐Grau, G., Vila, G., Cabezón, R., España, C., Andorrà, M., Saiz, A., Llufriú, S., Sepúlveda, M., Solà‐Valls, N., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820039116 · Cited by 189
Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis
Takewaki, D., Suda, W., Sato, W., Takayasu, L., Kumar, N., Kimura, K., Kaga, N., Mizuno, T., Miyake, S., Hattori, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011703117 · Cited by 194
Treatment of Depression Is Associated With Suppression of Nonspecific and Antigen-Specific TH1 Responses in Multiple Sclerosis
Mohr, D. C., Goodkin, D. E., Islar, J., Hauser, S. L., & Genain, C. P. (2001) · Archives of Neurology · doi:10.1001/archneur.58.7.1081 · Cited by 188
Prevalence and Neurobehavioral Correlates of Pathological Laughing and Crying in Multiple Sclerosis
Feinstein, A., Feinstein, K., Gray, T., & O'Connor, P. W. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550210050012 · Cited by 189
Fuzzy connectedness and image segmentation
Udupa, J. K., & Saha, P. K. (2003) · Proceedings of the IEEE · doi:10.1109/jproc.2003.817883 · Cited by 188
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability
Roosendaal, S., Bendfeldt, K., Vrenken, H., Polman, C., Borgwardt, S., Radue, E., Kappos, L., Pelletier, D., Hauser, S., Matthews, P., et al. (2011) · Multiple Sclerosis · doi:10.1177/1352458511404916 · Cited by 208
Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance
Horsfield, M. A., Lai, M., Webb, S., Barker, G. J., Tofts, P. S., Turner, R., Rudge, P., & Miller, D. H. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910360310 · Cited by 188
Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study
D'Alisa, S., Miscio, G., Baudo, S., Simone, A., Tesio, L., & Mauro, A. (2006) · Disability and Rehabilitation · doi:10.1080/09638280500191753 · Cited by 182
Acute and chronic pain syndromes in multiple sclerosis
Stenager, E., Knudsen, L., & Jensen, K. (1991) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1991.tb04937.x · Cited by 195
Depressed mood in multiple sclerosis: Relationship to capacity-demanding memory and attentional functioning.
Arnett, P. A., Higginson, C. I., Voss, W. D., Wright, B. N., Bender, W. I., Wurst, J. M., & Tippin, J. (1999) · Neuropsychology · doi:10.1037/0894-4105.13.3.434 · Cited by 187
Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial
ROG, D., NURMIKKO, T., & YOUNG, C. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.013 · Cited by 187
A 3‐year magnetic resonance imaging study of cortical lesions in relapse‐onset multiple sclerosis
Calabrese, M., Rocca, M., Atzori, M., Mattisi, I., Favaretto, A., Perini, P., Gallo, P., & Filippi, M. (2009) · Annals of Neurology · doi:10.1002/ana.21906 · Cited by 199
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
Filippini, G., Giovane, C. D., Vacchi, L., D’Amico, R., Pietrantonj, C. D., Beecher, D., & Salanti, G. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008933.pub2 · Cited by 191
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
Stein, M. S., Liu, Y., Gray, O. M., Baker, J., Kolbe, S., Ditchfield, M. R., Egan, G. F., Mitchell, P. J., Harrison, L. C., Butzkueven, H., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343274 · Cited by 186
The cognitive burden of multiple sclerosis in children
Banwell, B., & Anderson, P. E. (2005) · Neurology · doi:10.1212/01.wnl.0000152896.35341.51 · Cited by 186
Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability
Sosnoff, J. J., Sandroff, B. M., & Motl, R. W. (2012) · Gait & Posture · doi:10.1016/j.gaitpost.2011.11.027 · Cited by 186
Dysphagia in multiple sclerosis - prevalence and prognostic factors
Calcagno, P., Ruoppolo, G., Grasso, M. G., VINCENTIIS, M. D., & Paolucci, S. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.10062.x · Cited by 186
Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials
Paltamaa, J., Sjögren, T., Peurala, S. H., & Heinonen, A. O. (2012) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-1047 · Cited by 199
Plasma osteopontin levels in multiple sclerosis.
Comabella, M., Pericot, I., Goertsches, R., Nos, C., Castillo, M., Navarro, J. B., Río, J., & Montalbán, X. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.004 · Cited by 184
Thalamic neurodegeneration in relapsing-remitting multiple sclerosis
Wylezinska, M., Cifelli, A., Jezzard, P., Palace, J. A., Alecci, M., & Matthews, P. (2003) · Neurology · doi:10.1212/01.wnl.0000069464.22267.95 · Cited by 204
Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI
Cercignani, M., Iannucci, G., Rocca, M. A., Comı, G., Horsfield, M. A., & Filippi, M. (2000) · Neurology · doi:10.1212/wnl.54.5.1139 · Cited by 185
Age‐related disability in multiple sclerosis
Trojano, M., Liguori, M., Zimatore, G. B., Bugarini, R., Avolio, C., Paolicelli, D., Giuliani, F., Robertis, F. D., Marrosu, M. G., & Livrea, P. (2002) · Annals of Neurology · doi:10.1002/ana.10147 · Cited by 186
An epidemiological study of neuromyelitis optica in Cuba
Cabrera-Gómez, J. A., Kurtzke, J. F., González‐Quevedo, A., & Lara-Rodríguez, R. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0009-0 · Cited by 185
A medical definition of fatigue in multiple sclerosis
Mills, R. J., & Young, C. A. (2007) · QJM · doi:10.1093/qjmed/hcm122 · Cited by 185
Motor determinants of gait in 100 ambulatory patients with multiple sclerosis
Thoumie, P., Lamotte, D., Cantalloube, S., Faucher, M., & Amarenco, G. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1176oa · Cited by 185
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
Metz, L. M., Li, D. K. B., Traboulsee, A. L., Duquette, P., Eliasziw, M., Cerchiaro, G., Greenfield, J., Riddehough, A., Yeung, M., Kremenchutzky, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608889 · Cited by 186
Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis
Comi, G., Filippi, M., Martinelli, V., Campi, A., Rodegher, M., Alberoni, M., Sirabian, G., & Canal, N. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00168-2 · Cited by 185
Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis
Fazekas, F., Strasser‐Fuchs, S., Kollegger, H., Berger, T., Kristoferitsch, W., Schmidt, H., Enzinger, C., Schiefermeier, M., Schwarz, C., Kornek, B., et al. (2001) · Neurology · doi:10.1212/wnl.57.5.853 · Cited by 185
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
Vellinga, M. M., Oude Engberink, R. D., Seewann, A., Pouwels, P. J. W., Wattjes, M. P., van der Pol, S. M. A., Pering, C., Polman, C. H., de Vries, H. E., Geurts, J. J. G., et al. (2008) · Brain · doi:10.1093/brain/awn009 · Cited by 183
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
Sinnecker, T., Dörr, J., Pfueller, C. F., Harms, L., Ruprecht, K., Jarius, S., Brück, W., Niendorf, T., Wuerfel, J., & Paul, F. (2012) · Neurology · doi:10.1212/wnl.0b013e3182648bc8 · Cited by 214
Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study
Cadavid, D., Wolansky, L. J., Skurnick, J., Lincoln, J. A., Cheriyan, J., Szczepanowski, K., Kamin, S. S., Pachner, A. R., Halper, J., & Cook, S. D. (2009) · Neurology · doi:10.1212/01.wnl.0000345970.73354.17 · Cited by 184
Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis
Velikonja, O., Čurić, K., Ožura, A., & Jazbec, S. Š. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2010.03.006 · Cited by 184
In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Saito, M., Matsuzaki, T., Satou, Y., Yasunaga, J.-I., Saito, K., Arimura, K., Matsuoka, M., & Ohara, Y. (2009) · Retrovirology · doi:10.1186/1742-4690-6-19 · Cited by 184
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis
Rocca, M. A., Valsasina, P., Martinelli, V., Misci, P., Falini, A., Comı, G., & Filippi, M. (2012) · Neurology · doi:10.1212/wnl.0b013e31826d5f10 · Cited by 192
Diffuse Axonal and Tissue Injury in Patients With Multiple Sclerosis With Low Cerebral Lesion Load and No Disability
Stefano, N. D., Narayanan, S., Francis, S. J., Smith, S. M., Mortilla, M., Tartaglia, M. C., Bartolozzi, M. L., Guidi, L., Federico, A., & Arnold, D. L. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1565 · Cited by 184
Psychosocial factors associated with pain intensity, pain-related interference, and psychological functioning in persons with multiple sclerosis and pain
Osborne, T. L., Jensen, M. P., Ehde, D. M., Hanley, M. A., & Kraft, G. H. (2006) · Pain · doi:10.1016/j.pain.2006.07.017 · Cited by 191
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis
Meo, E. D., Portaccio, E., Giorgio, A., Ruano, L., Goretti, B., Niccolai, C., Patti, F., Chisari, C. G., Gallo, P., Grossi, P., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4920 · Cited by 190
Costs, quality of life and disease severity in multiple sclerosis: a cross‐sectional study in Sweden
Henriksson, F., Fredrikson, S., Masterman, T., & Jönsson, B. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00169.x · Cited by 185
Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis
Hind, D., Cotter, J., Thake, A., Bradburn, M., Cooper, C., Isaac, C., & House, A. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-5 · Cited by 180
Inflammation-related plasma and CSF biomarkers for multiple sclerosis
Huang, J., Khademi, M., Fugger, L., Lindhe, Ö., Novakova, L., Axelsson, M., Malmeström, C., Constantinescu, C., Lycke, J., Piehl, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912839117 · Cited by 194
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis
Kragt, J. J., van der Linden, F. A. H., Nielsen, J., Uitdehaag, B. M. J., & Polman, C. H. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070768 · Cited by 183
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study
Amato, M. P., Portaccio, E., Goretti, B., Zipoli, V., Iudice, A., Pina, D. D., Malentacchi, G., Sabatini, S., Annunziata, P., Falcini, M., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510380089 · Cited by 183
Understanding Falls in Multiple Sclerosis: Association of Mobility Status, Concerns About Falling, and Accumulated Impairments
Matsuda, P. N., Shumway‐Cook, A., Ciol, M. A., Bombardier, C. H., & Kartin, D. (2011) · Physical Therapy · doi:10.2522/ptj.20100380 · Cited by 183
Effects of Treatment for Depression on Fatigue in Multiple Sclerosis
Mohr, D. C., Hart, S. L., & Goldberg, A. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000074757.11682.96 · Cited by 183
A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis
Pagani, E., Filippi, M., Rocca, M. A., & Horsfield, M. A. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.008 · Cited by 183
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial
Page, E. L., Veillard, D., Laplaud, D. A., Hamonic, S., Wardi, R., Lebrun‐Frénay, C., Zagnoli, F., Wiertlewski, S., Deburghgraeve, V., Coustans, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61137-0 · Cited by 182
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire
Benedict, R., DUQUIN, J. A., Jurgensen, S., Rudick, R., Feitcher, J., Munschauer, F. E., Panzara, M. A., & Weinstock‐Guttman, B. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508090923 · Cited by 182
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
Heming, M., Li, X., Räuber, S. J., Mausberg, A. K., Börsch, A., Hartlehnert, M., Singhal, A., Lu, I., Fleischer, M., Szepanowski, F., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.12.011 · Cited by 181
On the nature of memory disturbance in multiple sclerosis
Rao, S. M., Leo, G. J., & Aubin-Faubert, P. S. (1989) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638908400926 · Cited by 182
Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial
Hommes, O. R., Sørensen, P. S., Fazekas, F., Enriquez, M. M., Koelmel, H. W., Fernández, Ó., Pozzilli, C., & O'Connor, P. W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17101-8 · Cited by 182
MRI of the corpus callosum in multiple sclerosis: association with disability
Öztürk, A., Smith, S., Gordon‐Lipkin, E. M., Harrison, D. M., Shiee, N., Pham, D., Caffo, B., Calabresi, P. A., & Reich, D. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458509353649 · Cited by 178
Quantitative functional measures in MS: What is a reliable change?
Schwid, S. R., Goodman, A. D., McDermott, M., Bever, C., & Cook, S. D. (2002) · Neurology · doi:10.1212/wnl.58.8.1294 · Cited by 181
Verbal fluency deficits in multiple sclerosis
Henry, J. D., & Beatty, W. W. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2005.10.006 · Cited by 181
Quantification of walking mobility in neurological disorders
Pearson, O. R., Busse, M. E., Deursen, R. W. M. V., & Wiles, C. M. (2004) · QJM · doi:10.1093/qjmed/hch084 · Cited by 181
The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis
Kisić-Tepavčević, D., Kostić, J., Basuroski, I., Stojsavljević, N., Pekmezovic, T. D., & Drulovic, J. S. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508093619 · Cited by 186
In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis.
de Stefano, N., Narayanan, S., Matthews, P. M., Francis, G., Antel, J. P., & Arnold, D. (1999) · Brain : a journal of neurology · doi:10.1093/brain/122.10.1933 · Cited by 196
A magnetization transfer histogram study of normal-appearing brain tissue in MS
Tortorella, C., Viti, B., Bozzali, M., Sormani, M. P., Rizzo, G., Gilardi, M. C., Comi, G., & Filippi, M. (2000) · Neurology · doi:10.1212/wnl.54.1.186 · Cited by 180

Authors: Kurtzke, J. F.
Affiliations: Georgetown University (US)
Corresponding author: Kurtzke, John F.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1983-11
Volume: 33
Issue: 11
Pages: 1444-1444
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.33.11.1444
OpenAlex: W2112165124
Cited by: 15,011
References: 13
Citations by year: 2026: 474 · 2025: 622 · 2024: 692 · 2023: 648 · 2022: 722 · 2021: 781 · 2020: 764 · 2019: 648 · 2018: 603 · 2017: 592 · 2016: 657 · 2015: 634 · 2014: 632 · 2013: 586 · 2012: 581
FWCI: 9.57
Type: journal article
Language: en
Open access: closed
Locations: Neurology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
Keywords: multiple sclerosis, Expanded Disability Status Scale, disability assessment, neurological deficit, functional systems, pyramidal system, cerebellar function, brainstem, sensory impairment, bowel and bladder dysfunction, visual impairment
MeSH terms: Humans, Multiple Sclerosis, Nervous System Diseases, Neurologic Examination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks